These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2062464)

  • 21. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D; Chambers CM; Keller RK; Ness GC
    Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
    Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
    Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
    Vaziri ND; Sato T; Liang K
    Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of lymphocyte proliferation by cholesterol: the role of endogenous sterol metabolism and low density lipoprotein receptors.
    Cuthbert JA; Lipsky PE
    Int J Tissue React; 1987; 9(6):447-57. PubMed ID: 3448024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase unmask transcriptional regulation of hepatic low-density lipoprotein receptor gene expression by dietary cholesterol.
    Lopez D; Ness GC
    Arch Biochem Biophys; 1997 Aug; 344(1):215-9. PubMed ID: 9244400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent responsiveness of frog liver low-density lipoprotein receptor and HMGCoA reductase to estrogen treatment.
    Di Croce L; Bruscalupi G; Trentalance A
    Pflugers Arch; 1997 Dec; 435(1):107-11. PubMed ID: 9359909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL receptor gene transcription is selectively induced by t10c12-CLA but not by c9t11-CLA in the human hepatoma cell line HepG2.
    Ringseis R; König B; Leuner B; Schubert S; Nass N; Stangl G; Eder K
    Biochim Biophys Acta; 2006 Oct; 1761(10):1235-43. PubMed ID: 16982210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment.
    Di Croce L; Bruscalupi G; Trentalance A
    Biochem Biophys Res Commun; 1996 Jul; 224(2):345-50. PubMed ID: 8702393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    al Rayyes O; Wallmark A; Florén CH
    Hepatology; 1997 Apr; 25(4):991-4. PubMed ID: 9096609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulation of hepatocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase in primary cell cultures through low density lipoproteins].
    Gaertner U
    Z Gastroenterol; 1978 Apr; 16(4):251-6. PubMed ID: 207027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin.
    Suárez Y; Fernández C; Gómez-Coronado D; Ferruelo AJ; Dávalos A; Martínez-Botas J; Lasunción MA
    Cardiovasc Res; 2004 Nov; 64(2):346-55. PubMed ID: 15485695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Hydroxy-3-methylglutaryl coenzyme A reductase in anencephalic and normal human fetal liver.
    Carr BR; Rainey WE; Mason JI
    J Clin Invest; 1985 Nov; 76(5):1946-9. PubMed ID: 2997298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis.
    Nguyen LB; Shefer S; Salen G; Ness GC; Tint GS; Zaki FG; Rani I
    J Clin Invest; 1990 Sep; 86(3):923-31. PubMed ID: 2394840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cholesterol is hyperresponsive to statin in ABCG5/ABCG8 transgenic mice.
    Tang W; Ma Y; Yu L
    Hepatology; 2006 Nov; 44(5):1259-66. PubMed ID: 17058264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human carotid atherosclerotic lesion protein components decrease cholesterol biosynthesis rate in macrophages through 3-hydroxy-3-methylglutaryl-CoA reductase regulation.
    Cohen E; Aviram M; Khatib S; Rosenblat M; Vaya J
    Biofactors; 2015; 41(1):28-34. PubMed ID: 25639207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical controls of liver cholesterol biosynthesis.
    Ott DB; Lachance PA
    Am J Clin Nutr; 1981 Oct; 34(10):2295-306. PubMed ID: 6170219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats.
    Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S
    Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HMG-CoA reductase inhibitor for therapy of patients with hyperlipoproteinemia ].
    Jingami H
    Nihon Rinsho; 1994 Dec; 52(12):3271-8. PubMed ID: 7853722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.